This inventor holds 1 USPTO granted patent. Top assignee: Pharmablock Sciences (Nanjing), Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Lisha Wang: Innovator in Pharmaceutical Research
Introduction: Lisha Wang is a notable inventor based in Jiangsu, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. Her work is characterized by a commitment to advancing medical science through innovative solutions.
Latest Patents: Lisha Wang holds a patent for a CBP/EP300 inhibitor and its use in preparing drugs for diseases mediated by CBP and/or EP300. This patent includes a compound represented by Formula (I), a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The implications of her research are profound, as it opens new avenues for treating various medical conditions.
Career Highlights: Lisha Wang is currently employed at Pharmablock Sciences (Nanjing), Inc., where she continues to push the boundaries of pharmaceutical research. Her dedication to her work has led to the successful development of innovative compounds that have the potential to improve patient outcomes.
Collaborations: Lisha collaborates with her coworker, Enge Zhang, who is also a talented professional in the field. Together, they contribute to the advancement of pharmaceutical research and development.
Conclusion: Lisha Wang's contributions to the field of pharmaceuticals through her innovative patent work exemplify the impact of dedicated inventors in advancing medical science. Her ongoing research promises to yield significant benefits for the treatment of diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile